GLP-1 receptor agonists are a type of medication that mimics a hormone naturally produced in your gut called glucagon-like peptide-1 (GLP-1)
During the subsequent 17-week off-treatment period, the patients began to regain weight and showed some increases in type 2 diabetes progression, resulting in a 88% diabetes risk reduction after the off-period
Braster Q, Silvestre-Roig C, Hartwig H, Kusters P, Aarts S, den Toom M, et al
contrast-enhanced CT scanning if diagnosis uncertain or complications suspected Management principles align with British Society of Gastroenterology guidance for acute pancreatitis and typically include: Hospital admission for most cases, with high-dependency or intensive care for severe presentations based on severity scoring Intravenous fluid resuscitation to maintain organ perfusion Analgesia (often requiring opioid medications for adequate pain control) Early oral or enteral nutrition when clinically safe and feasible, rather than prolonged fasting Treatment of underlying causes (e.g., endoscopic retrograde cholangiopancreatography for biliary obstruction) Tirzepatide should not be restarted following confirmed pancreatitis, as specified in the MHRA product information, and alternative diabetes or weight management therapies should be considered

Indian doctors said the analysis was unlikely to change how these drugs are prescribed here in the short term Indian practice still runs largely on a body mass index cut-off, not a comparison between drugs but that the picture is set to change as evidence accumulates